Leavell Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $859K | Sell |
35,669
-1,990
| -5% | -$52.1K | 0.03% | 346 |
|
|
2026
Q1 | $1.06M | Buy |
37,659
+2,122
| +6% | +$56.5K | 0.04% | 305 |
|
|
2025
Q4 | $885K | Sell |
35,537
-4,917
| -12% | -$124K | 0.04% | 314 |
|
|
2025
Q3 | $1.03M | Sell |
40,454
-2,744
| -6% | -$67.7K | 0.04% | 296 |
|
|
2025
Q2 | $1.05M | Sell |
43,198
-6,198
| -13% | -$145K | 0.05% | 293 |
|
|
2025
Q1 | $1.25M | Buy |
49,396
+209
| +0.4% | +$5.47K | 0.06% | 258 |
|
|
2024
Q4 | $1.3M | Sell |
49,187
-9,928
| -17% | -$269K | 0.06% | 248 |
|
|
2024
Q3 | $1.71M | Sell |
59,115
-2,429
| -4% | -$70.9K | 0.09% | 219 |
|
|
2024
Q2 | $1.72M | Sell |
61,544
-2,228
| -3% | -$61.3K | 0.1% | 198 |
|
|
2024
Q1 | $1.77M | Sell |
63,772
-7,760
| -11% | -$215K | 0.1% | 191 |
|
|
2023
Q4 | $2.06M | Sell |
71,532
-10,782
| -13% | -$326K | 0.13% | 161 |
|
|
2023
Q3 | $2.73M | Sell |
82,314
-17,195
| -17% | -$608K | 0.19% | 124 |
|
|
2023
Q2 | $3.65M | Sell |
99,509
-4,471
| -4% | -$174K | 0.25% | 106 |
|
|
2023
Q1 | $4.24M | Sell |
103,980
-1,880
| -2% | -$81.2K | 0.3% | 88 |
|
|
2022
Q4 | $5.42M | Sell |
105,860
-2,390
| -2% | -$115K | 0.41% | 72 |
|
|
2022
Q3 | $4.74M | Sell |
108,250
-4,771
| -4% | -$232K | 0.38% | 79 |
|
|
2022
Q2 | $5.93M | Buy |
113,021
+3,171
| +3% | +$162K | 0.45% | 69 |
|
|
2022
Q1 | $5.69M | Sell |
109,850
-12
| -0% | -$623 | 0.39% | 75 |
|
|
2021
Q4 | $6.49M | Buy |
109,862
+339
| +0.3% | +$16.8K | 0.43% | 69 |
|
|
2021
Q3 | $4.71M | Buy |
109,523
+3,284
| +3% | +$145K | 0.35% | 80 |
|
|
2021
Q2 | $3.85M | Hold |
106,239
| – | – | 0.31% | 97 |
|
|
2021
Q1 | $3.85M | Sell |
106,239
-11,680
| -10% | -$415K | 0.31% | 97 |
|
|
2020
Q4 | $4.34M | Sell |
117,919
-5,705
| -5% | -$209K | 0.38% | 76 |
|
|
2020
Q3 | $4.3M | Sell |
123,624
-2,146
| -2% | -$75.2K | 0.37% | 76 |
|
|
2020
Q2 | $3.9M | Buy |
125,770
+3,061
| +2% | +$104K | 0.38% | 80 |
|
|
2020
Q1 | $3.8M | Sell |
122,709
-18,951
| -13% | -$646K | 0.44% | 69 |
|
|
2019
Q4 | $5.27M | Sell |
141,660
-2,134
| -1% | -$76K | 0.49% | 60 |
|
|
2019
Q3 | $4.9M | Buy |
143,794
+886
| +0.6% | +$32.2K | 0.5% | 57 |
|
|
2019
Q2 | $5.87M | Buy |
142,908
+147
| +0.1% | +$5.84K | 0.62% | 42 |
|
|
2019
Q1 | $5.75M | Buy |
142,761
+2,710
| +2% | +$109K | 0.64% | 40 |
|
|
2018
Q4 | $5.8M | Buy |
140,051
+3,794
| +3% | +$157K | 0.73% | 35 |
|
|
2018
Q3 | $5.7M | Sell |
136,257
-1,501
| -1% | -$57.8K | 0.61% | 42 |
|
|
2018
Q2 | $4.74M | Sell |
137,758
-3,382
| -2% | -$116K | 0.54% | 50 |
|
|
2018
Q1 | $4.75M | Buy |
141,140
+3,032
| +2% | +$104K | 0.55% | 51 |
|
|
2017
Q4 | $4.75M | Sell |
138,108
-5,594
| -4% | -$191K | 0.56% | 49 |
|
|
2017
Q3 | $4.87M | Sell |
143,702
-2,099
| -1% | -$67.5K | 0.6% | 48 |
|
|
2017
Q2 | $4.65M | Buy |
145,801
+2,127
| +1% | +$67.1K | 0.59% | 50 |
|
|
2017
Q1 | $4.66M | Buy |
143,674
+3,301
| +2% | +$104K | 0.6% | 43 |
|
|
2016
Q4 | $4.33M | Sell |
140,373
-293
| -0.2% | -$8.95K | 0.6% | 43 |
|
|
2016
Q3 | $4.52M | Buy |
140,666
+2,421
| +2% | +$81K | 0.67% | 37 |
|
|
2016
Q2 | $4.62M | Sell |
138,245
-1,945
| -1% | -$62.1K | 0.68% | 37 |
|
|
2016
Q1 | $3.94M | Buy |
140,190
+5,682
| +4% | +$162K | 0.59% | 43 |
|
|
2015
Q4 | $4.12M | Buy |
134,508
+4,658
| +4% | +$147K | 0.6% | 35 |
|
|
2015
Q3 | $3.87M | Buy |
129,850
+26,309
| +25% | +$844K | 0.61% | 33 |
|
|
2015
Q2 | $3.29M | Buy |
103,541
+15,568
| +18% | +$507K | 0.51% | 52 |
|
|
2015
Q1 | $2.9M | Buy |
87,973
+1,897
| +2% | +$60.3K | 0.44% | 66 |
|
|
2014
Q4 | $2.54M | Buy |
86,076
+5,889
| +7% | +$169K | 0.39% | 75 |
|
|
2014
Q3 | $2.25M | Buy |
80,187
+5,101
| +7% | +$143K | 0.36% | 87 |
|
|
2014
Q2 | $2.11M | Buy |
75,086
+9,697
| +15% | +$276K | 0.33% | 95 |
|
|
2014
Q1 | $1.99M | Buy |
65,389
+421
| +0.6% | +$12.6K | 0.33% | 93 |
|
|
2013
Q4 | $1.89M | Buy |
64,968
+951
| +1% | +$27.7K | 0.32% | 96 |
|
|
2013
Q3 | $1.75M | Buy |
64,017
+3,373
| +6% | +$91.8K | 0.31% | 90 |
|
|
2013
Q2 | $1.61M | Buy |
+60,644
| New | +$1.68M | 0.3% | 90 |
|
Other funds holding PFE
Leavell Investment Management's PFE Position: Q2 2026 in Review
Leavell Investment Management reduced its Pfizer (PFE) stake by 5.3% in Q2 2026, selling an estimated $52.1K and leaving 35,669 shares worth $859K. The position accounts for 0.03% of the portfolio, ranked #346.
Leavell Investment Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.49M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Leavell Investment Management held 35,669 shares of Pfizer worth $859K as of Q2 2026.
- Leavell Investment Management sold 1,990 Pfizer shares in Q2 2026, an estimated $52.1K.
- Pfizer made up 0.03% of Leavell Investment Management's portfolio in Q2 2026, its #346 holding.
- Leavell Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Leavell Investment Management's Pfizer position peaked at $6.49M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Leavell Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.